ANI Pharmaceuticals (ANIP)

[Just the facts maam]

Catty, I understand your frustration, however in assessing your decision to sell consider the following:

1) Dr Michael Snabes appears to be a Medical Director PD-MD3 with Abbvie's Clinical Development and GPRD (Global Research and Development). I have yet to find any documented connection between Dr Snabes and any product he would be developing for Abbvie. All signs still point to Libigel.

http://www.zoominfo.com/p/Michael-Snabes/502826556

2) We are still waiting on the three new patents. Information supporting the breast cancer risk reduction claims will most likely be listed. It should identify if it was based additional analysis. The information could be a game changer.

3) The Cold Genesys Bladder Cancer trial will be completed for primary outcome measures in June 2017.

As for me the undisclosed Libigel CV Risk reduction is what got to increase my position and it is what I will be seeing to the end. If I am right everything else is simply gravy.